{"name":"Symphogen","permalink":"symphogen","crunchbase_url":"http://www.crunchbase.com/company/symphogen","homepage_url":"http://www.symphogen.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@symphogen.com","phone_number":"+45 4526 5050","description":"Recombinant polyclonal antibodies ","created_at":"Fri Apr 17 12:25:48 UTC 2009","updated_at":"Mon Feb 14 12:01:57 UTC 2011","overview":"<p>Symphogen is the leader in developing recombinant polyclonal antibodies (rpAb), a new class of biopharmaceuticals for the treatment or prophylaxis of serious human diseases.</p>","image":{"available_sizes":[[[150,61],"assets/images/resized/0004/1671/41671v1-max-150x150.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-250x250.png"],[[194,79],"assets/images/resized/0004/1671/41671v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Co-founder and CFO","person":{"first_name":"Thomas","last_name":"Feldthus","permalink":"thomas-feldthus","image":{"available_sizes":[[[112,150],"assets/images/resized/0004/5647/45647v1-max-150x150.jpg"],[[180,240],"assets/images/resized/0004/5647/45647v1-max-250x250.jpg"],[[180,240],"assets/images/resized/0004/5647/45647v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Co-founder and CEO","person":{"first_name":"Kirsten","last_name":"Drejer","permalink":"kirsten-drejer","image":{"available_sizes":[[[112,150],"assets/images/resized/0004/5645/45645v1-max-150x150.jpg"],[[180,240],"assets/images/resized/0004/5645/45645v1-max-250x250.jpg"],[[180,240],"assets/images/resized/0004/5645/45645v1-max-450x450.jpg"]],"attribution":""}}},{"is_past":false,"title":"Co-founder and CSO","person":{"first_name":"John","last_name":"Haurum","permalink":"john-haurum","image":{"available_sizes":[[[112,150],"assets/images/resized/0004/5646/45646v1-max-150x150.jpg"],[[180,240],"assets/images/resized/0004/5646/45646v1-max-250x250.jpg"],[[180,240],"assets/images/resized/0004/5646/45646v1-max-450x450.jpg"]],"attribution":""}}}],"competitions":[],"providerships":[],"total_money_raised":"€293M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.symphogen.com/web/guest/newsarchive/readmore?p_p_id=56_INSTANCE_ZUuU&articleId=90","source_description":"Symphogen secures â‚¬ 33 million financing to support clinical development of antibody products","raised_amount":33000000,"raised_currency_code":"EUR","funded_year":2009,"funded_month":2,"funded_day":2,"investments":[{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"","source_description":"Capital Funding Report","raised_amount":null,"raised_currency_code":"USD","funded_year":2008,"funded_month":6,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"GenenFUND","permalink":"genenfund","image":null},"person":null}]},{"round_code":"d","source_url":"http://bulletin.sciencebusiness.net/sb/login.php?page=/ebulletins/showissue.php3?page=/548/art/4700","source_description":"Symphogen gets $25M for clinical trials for bleeding treatment","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2006,"funded_month":1,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"Takeda Research Investment","permalink":"takeda-research-investment","image":{"available_sizes":[[[89,45],"assets/images/resized/0008/4399/84399v1-max-150x150.jpg"],[[89,45],"assets/images/resized/0008/4399/84399v1-max-250x250.jpg"],[[89,45],"assets/images/resized/0008/4399/84399v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"LD Pensions","permalink":"ld-pensions","image":{"available_sizes":[[[150,31],"assets/images/resized/0006/8573/68573v1-max-150x150.png"],[[250,53],"assets/images/resized/0006/8573/68573v1-max-250x250.png"],[[330,70],"assets/images/resized/0006/8573/68573v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Scandinavian Life Science Venture","permalink":"scandinavian-life-science-venture-2","image":{"available_sizes":[[[150,28],"assets/images/resized/0010/3593/103593v1-max-150x150.png"],[[250,47],"assets/images/resized/0010/3593/103593v1-max-250x250.png"],[[250,47],"assets/images/resized/0010/3593/103593v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Novo A/S","permalink":"novo-a-s","image":null},"person":null},{"company":null,"financial_org":{"name":"Vaekstfonden","permalink":"vaekstfonden","image":{"available_sizes":[[[150,8],"assets/images/resized/0004/9946/49946v1-max-150x150.png"],[[200,11],"assets/images/resized/0004/9946/49946v1-max-250x250.png"],[[200,11],"assets/images/resized/0004/9946/49946v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/01/symphogen-closes-100m-round-of.html","source_description":"Symphogen Closes â‚¬100M Round of Financing","raised_amount":100000000,"raised_currency_code":"EUR","funded_year":2011,"funded_month":1,"funded_day":6,"investments":[{"company":null,"financial_org":{"name":"Novo A/S","permalink":"novo-a-s","image":null},"person":null},{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"The Danish Pension Fund PKA","permalink":"the-danish-pension-fund-pka","image":null},"person":null}]},{"round_code":"f","source_url":"http://onbiovc.com/symphogen-as-series-f-1354m/","source_description":"Symphogen, AS: Series F $135.4M","raised_amount":135400000,"raised_currency_code":"USD","funded_year":2011,"funded_month":2,"funded_day":14,"investments":[{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Novo A/S","permalink":"novo-a-s","image":null},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"Symphogen A/S","address1":"Elektrovej Building 375","address2":"","zip_code":"DK-2800","city":"Lyngby","state_code":null,"country_code":"DNK","latitude":55.783256,"longitude":12.515066}],"milestones":[{"description":"Symphogen lines up record $131M venture round.","stoned_year":2011,"stoned_month":1,"stoned_day":6,"source_url":"http://www.fiercebiotech.com/story/symphogen-lines-record-131m-venture-round/2011-01-06?utm_medium=rss&utm_source=rss","source_text":"","source_description":"Symphogen lines up record $131M venture round","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Symphogen","permalink":"symphogen"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,96],"assets/images/resized/0004/3928/43928v1-max-150x150.jpg"],[[250,161],"assets/images/resized/0004/3928/43928v1-max-250x250.jpg"],[[450,290],"assets/images/resized/0004/3928/43928v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}